Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wilke

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Rheumatology|May 1, 1982
Myalgia as the primary manifestation of spontaneously resolving hyperthyroidismA M Segal, L R Sheeler, W S Wilke
The Journal of Rheumatology|July 1, 1981
Hypothyroidism with presenting symptoms of fibrositisW S Wilke, L R Sheeler, W S Makarowski
Cleveland Clinic Journal of Medicine|May 1, 1989
Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritisP L Krall, D J Mazanec, W S Wilke
Biochemistry|November 26, 1999
Importance of F1-ATPase residue alpha-Arg-376 for catalytic transition state stabilizationS Nadanaciva, J Weber, S Wilke-Mounts, et al.
The Journal of Biological Chemistry|April 5, 1993
Lysine 155 in beta-subunit is a catalytic residue of Escherichia coli F1 ATPaseA E Senior, S Wilke-Mounts, M K al-Shawi
Archives of Biochemistry and Biophysics|March 1, 1994
Tryptophan-free Escherichia coli F1-ATPaseS Wilke-Mounts, J Weber, E Grell, et al.
The Journal of Biological Chemistry|February 7, 1997
F1-ATPase, roles of three catalytic site residuesS Löbau, J Weber, S Wilke-Mounts, et al.
The Journal of Biological Chemistry|April 15, 1994
Tryptophan fluorescence provides a direct probe of nucleotide binding in the noncatalytic sites of Escherichia coli F1-ATPaseJ Weber, S Wilke-Mounts, E Grell, et al.
Current Opinion in Microbiology|September 1, 2005
Beta-lactam antibiotic resistance: a current structural perspectiveMark S Wilke, Andrew L Lovering, Natalie C J Strynadka
The Journal of Biological Chemistry|September 8, 1995
alpha-Aspartate 261 is a key residue in noncatalytic sites of Escherichia coli F1-ATPaseJ Weber, C Bowman, S Wilke-Mounts, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Rheumatology|May 1, 1982
Myalgia as the primary manifestation of spontaneously resolving hyperthyroidismA M Segal, L R Sheeler, W S Wilke
The Journal of Rheumatology|July 1, 1981
Hypothyroidism with presenting symptoms of fibrositisW S Wilke, L R Sheeler, W S Makarowski
Cleveland Clinic Journal of Medicine|May 1, 1989
Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritisP L Krall, D J Mazanec, W S Wilke
Biochemistry|November 26, 1999
Importance of F1-ATPase residue alpha-Arg-376 for catalytic transition state stabilizationS Nadanaciva, J Weber, S Wilke-Mounts, et al.
The Journal of Biological Chemistry|April 5, 1993
Lysine 155 in beta-subunit is a catalytic residue of Escherichia coli F1 ATPaseA E Senior, S Wilke-Mounts, M K al-Shawi
Archives of Biochemistry and Biophysics|March 1, 1994
Tryptophan-free Escherichia coli F1-ATPaseS Wilke-Mounts, J Weber, E Grell, et al.
The Journal of Biological Chemistry|February 7, 1997
F1-ATPase, roles of three catalytic site residuesS Löbau, J Weber, S Wilke-Mounts, et al.
The Journal of Biological Chemistry|April 15, 1994
Tryptophan fluorescence provides a direct probe of nucleotide binding in the noncatalytic sites of Escherichia coli F1-ATPaseJ Weber, S Wilke-Mounts, E Grell, et al.
Current Opinion in Microbiology|September 1, 2005
Beta-lactam antibiotic resistance: a current structural perspectiveMark S Wilke, Andrew L Lovering, Natalie C J Strynadka
The Journal of Biological Chemistry|September 8, 1995
alpha-Aspartate 261 is a key residue in noncatalytic sites of Escherichia coli F1-ATPaseJ Weber, C Bowman, S Wilke-Mounts, et al.
Pageof 13